Access Reference
Access Reference
 |
 Avery Easy-Access Reference Binder  US $4.99
|
| Powered by phpBay Pro |
 |
Avery® Easy Access Round Ring Reference Binder List Price: $26.78  |
|
Avery® Easy Access Round Ring Reference Binder |
 |
Avery® Easy Access Round Ring Reference Binder List Price: $26.78 |
|
Avery® Easy Access Round Ring Reference Binder |
 |
Avery® Easy Access Round Ring Reference Binder List Price: $26.78 |
|
Avery® Easy Access Round Ring Reference Binder |
 |
Techniques of Physical Diagnosis: A Visual Approach (The Head and Neck, Part 2A: Head and Eyes) |
 |
Techniques of Physical Diagnosis: A Visual Approach (The Head and Neck, Part 2B: Ear, Nose, Throat and Neck) |
 |
HINGE SELF CLOSE3"BB CD2 [Misc.] List Price: $42.19 Sale Price: $24.38 Average Rating:  |
|
Sold as one unit. (1 unit = Card.) 3". Bright Brass. Adjustable self-closing speed. Provides 2 way access for swinging doors. 30 lb weight capacity. References National# 115-303. Clamshell/2. Manufacturer number: 01-3555-310... |
 |
UMF 4010 Low Access Power Exam Table with Programmable Foot Control, Slate Blue Sale Price: $12,760.66 |
|
UMF 4010 Low Access Power Exam Table with Programmable Foot Control, Slate BlueUMF 4010 Low Access Power Exam Table provides accessibility and comfort. Lowers to a height of 19" and can handle a patient capacity of up to 600 lbs... |
 |
UMF 4070 Low Access Exam Table, Bright White Sale Price: $5,449.69 |
|
UMF 4070 Low Access Exam Table, Bright WhiteUMF 4070 Low Access Power Exam Table can lift up to 600 lbs. and adjusts from a height of 19" up to 35" . Comfortable, stable. Seamless, easy-to-clean top. Stainless steel leg section pullout with removable upholstered leg pad cushion, removable 4-qt... |
Here are some more information for Access Reference:
Access to Medicine: Responses From Pharmaceutical Industry Heavyweights
Recent statements, initiatives, and studies from three of the largest producers of pharmaceuticals in the world confirm that pharmaceutical patent holders are taking steps to improve access to medicines in developing countries. GSK, Johnson & Johnson, and Novartis all have publicly available information on their efforts to improve access to medicines. These efforts will be summarized in this article for reference.
GSK on Access to Medicines
GlaxoSmithKline is on the leading edge of providing access to medicines. Their programs range from making essential medicines more affordable to granting voluntary licenses to developing countries. Highlights of GSK’s programs to increase access to medicines include the following:
1. The Orange Card initiative in Lithuania covers the cost of medications for the poorest of Lithuania’s senior citizens. The program launched in July 2004 and by February 2005 more than 3,500 patients applied for the card and 107 pharmacies registered to participate.
2. GSK provides antiretroviral medications to fight AIDS at significantly reduced prices to developing countries.
3. In 2005 GSK devoted 14 development programs to find treatments for nine deadly diseases that plague the developing world.
4. In 2004, GSK helped provide access to medicines in the developing world by shipping 32.7 million Combivir tablets to developing countries.
Johnson & Johnson on Access to Medicine
Johnson & Johnson companies offer increased access to medicine in developing countries through a variety of efforts in multiple locations. These efforts range from providing AIDS/HIV medications to disaster relief programs in the United States and abroad. In the last two years over 320,000 patients have received care from Johnson & Johnson programs. The particular program that applies to United States patients is called Access2Wellness and provides access to apply to Johnson & Johnson aid programs.
Novartis on Access to Medicines
Novartis is committed to helping resolve the problem of limited access to medicines in developing countries. They want to approach the problem with an integrated, multi-pronged strategy. The first step is to acknowledge the complexity of the issue and realize that to tackle the access to medicine problem one must address it from multiple angles. Access to medicine is about having properly governed health care systems, working to alleviate poverty, and other societal issues. Novartis also advocates special pricing arrangements for the poorest countries to have access to medicines that will treat their populations without exposing patent holders to copyright infringement. This protection for intellectual property will come from the WTO’s TRIPS agreement, which Novartis strongly supports.
About the Author
James Wachai is a professional blogger who writes for Pharmaceutical News 2.0, a leading aggregator of pharmaceutical industry related content. To see additional content on access to medicine, or specifically access to medicine in West Virginia, pharmaceutical patents, drug patents, compulsory licensing and more, visit Pharmaceutical News 2.0 today.
How do I contact yahoo customer care in reference to no access to email?
phone 408-349-1572
Liebert Mobile iPhone App Offers Global Access
Announcing the launch of the Liebert Mobile iPhone App, a dynamic new application delivering the latest news, resources, press releases, research, and multimedia content directly to your iPhone. Convenient access to information across the biomedical, biotechnology, medicine, surgery, and nursing, integrative medicine, environmental, and public health fields is available with this free ...
Thanks for visiting!
